Subsidiaries of Johnson & Johnson have agreed to pay $5.9 million to settle a lawsuit with Montana over how an anti-psychotic drug was marketed, state Attorney General Tim Fox said.
Pfizer is recalling some lots of its antidepressant Effexor XR because a single capsule of a...
Scientists have modified genes in the blood cells of HIV patients to help them resist the AIDS...
A lawyer for two drug companies told the Arkansas Supreme Court that the state improperly relied on federal regulations in a lawsuit that resulted in a $1.2 billion award.
A consumer advocacy group is calling on the Food and Drug Administration to add a bold warning label to popular testosterone drugs for men in light of growing evidence that the hormone treatments can increase the risk of heart attack.
Eli Lilly is buying a privately held, poultry vaccine maker to strengthen its Elanco animal health subsidiary. No terms were released, but Lilly said Monday that its 2014 earnings forecast will be trimmed due to acquisition costs.
The head of the Food and Drug Administration said Friday that her agency will add more inspectors in India to better monitor drugs from the country's burgeoning pharmaceutical industry, even as her agency also seeks closer cooperation from Indian regulators.
In a federal posting Friday, the agency announced a two-day meeting next month to discuss overhauling the system known as the over-the-counter monograph. The system was put in place in 1972 as a way to set dosing, labeling and other standards for hundreds of nonprescription drug ingredients, everything from aspirin to anti-bacterial hand scrubs.
New York's attorney general has announced a settlement with generic drug manufacturers Ranbaxy Pharmaceuticals and Teva Pharmaceuticals USA intended to ensure they don't collude to restrict competition. According to Attorney General Eric Schneiderman, the settlement ends their 2010 agreement against competing over dozens of drugs.
There's one big reason why the United States has a dearth of execution drugs so acute that some states are considering solutions such as firing squads and gas chambers: Europe won't allow the drugs to be exported because of its fierce hostility to capital punishment.
Actavis PLC says it will acquire fellow drugmaker Forest Laboratories Inc. in a cash-and-stock deal worth about $25 billion. The deal would create a combined company spanning both generic and branded drugs, including Forest's Alzheimer's treatment Namenda and the antidepressant Lexapro.
Johnson & Johnson said Friday that the Food and Drug Administration has rejected — for a third time — its application to expand use of the blood thinner Xarelto to reduce dangerous blood clots and related problems in patients with coronary artery disease.
A ruling temporarily prohibiting a compounding pharmacy from selling execution drugs to Missouri could have implications across the country, a legal expert said Thursday. U.S. District Judge Terence Kern in Tulsa, Okla., issued a temporary restraining order Wednesday in a suit filed on behalf of condemned Missouri inmate Michael Taylor.
Three U.S. senators are raising concerns about the Food and Drug Administration's approval of a powerful painkiller called Zohydro, which experts say could add to the national epidemic of prescription drug abuse.
The use of gummies as a form of drug delivery is exploding. Just do a Google image search for “vitamin gummies” and you will see what I mean. Currently, it seems like gummies are most popular with vitamin and supplement makers – both for children and adults – and really what’s not to like about gummies?
A Missouri inmate scheduled for execution this month is asking a federal judge to bar a Tulsa compounding pharmacy from providing the drug to be used in his lethal injection. The lawsuit alleges the drug could cause "an unnecessarily long and inhumane execution."
A majority of federal health experts say that new research is not strong enough to conclude that naproxen, the pain reliever in Aleve and many other medications, is safer on the heart than rival drugs used by millions of Americans to treat aches and pains.
Leading cancer experts say Europe's antiquated drug regulatory system is stopping children from getting life-saving medicines and are calling for changes that would remove a loophole that allows companies to skip developing medicines for children already approved for adults.
Swiss food and drink giant Nestlé and French cosmetics company L'Oréal have approved a deal to transfer ownership of Swiss dermatology pharmaceuticals company Galderma. The companies say L'Oréal will buy 48.5 million of its own shares, or 8 percent of its share capital, from Nestlé and give Nestlé its 50 percent stake in Galderma, which has been a 50/50 joint venture between them.
The key question is whether naproxen — the key ingredient in Bayer's Aleve and many other generic pain pills — carries a lower risk of heart attack and stroke than rival medications like ibuprofen, sold as Advil by Pfizer, among others.
Teva Pharmaceutical Industries says the federal government is investigating its marketing of its multiple sclerosis drug Copaxone and Parkinson's disease treatment Azilect. It says the government is conducting a civil investigation into possible violations of the False Claims Act, a law that allows the government to collect damages reported by private citizens.
Merck & Co.'s hot experimental cancer drug, already closely watched by investors, got more attention Wednesday after the company announced new alliances with three other drugmakers to test it in combination with their drugs.
The Accelerating Medicines Partnership, announced Tuesday, will focus on the early part of drug research: identifying biological targets present in a disease, such as abnormal genes or particular proteins.
Forest Labs said Monday it completed its $2.9 billion purchase of Aptalis, a company that makes treatments for gastrointestinal problems and cystic fibrosis. Forest said the acquisition of Aptalis will give it about $700 million in revenue in its next fiscal year.
Valeant Pharmaceuticals is looking to expand its skin care business by buying PreCision Dermatology for $475 million. Cumberland, R.I.-based PreCision Dermatology makes treatments for skin ailments such as acne and atopic dermatitis, an itchy, chronic skin inflammation.
Drug developer Bristol-Myers Squibb Co. has received a $2.7 billion payment from Anglo-Swedish counterpart AstraZeneca PLC as part of the sale of its global diabetes business, a deal that could eventually be worth more than $4 billion.
The Food and Drug Administration cleared Vanda Pharmaceuticals' Hetlioz capsules for patients who have problems sleeping because they can't detect light. The condition, called non-24-hour disorder, is estimated to affect up to 100,000 Americans, most of whom are totally blind.
Abbott Laboratories is closing one of its manufacturing plants in the Puerto Rico town of Barceloneta next year, delivering another blow to the U.S. territory's once-thriving pharmaceutical sector, officials said Thursday.
- Page 1